Clinical Trials Insight: 700049856

Trial Profile

Clinical Trials Insight: 700049856

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2009

At a glance

  • Drugs Iobenguane (Primary)
  • Indications Paraganglioma; Phaeochromocytoma
  • Focus Adverse reactions
  • Sponsors Molecular Insight Pharmaceuticals
  • Most Recent Events

    • 12 Oct 2009 New trial record.
    • 02 Oct 2009 12-month efficacy data were presented at the North American Neuroendocrine Tumor Society (NANETS) 2009 Neuroendocrine Tumor Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top